Integrin αvβ6-targeted PET in Malignant Tumors

Clinical trial NCT05835570 · RECRUITING

Trial details

NCT number: NCT05835570
Sponsor: Zhongnan Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Malignant Neoplasm PET/CT Non-Small Cell Lung Cancer Breast Cancer, Metastatic

Start date: 2023-01-01
Primary completion: 2025-11-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.